Analysis and prediction of drug–drug interaction by minimum redundancy maximum relevance and incremental feature selection

Drug–drug interaction (DDI) defines a situation in which one drug affects the activity of another when both are administered together. DDI is a common cause of adverse drug reactions and sometimes also leads to improved therapeutic effects. Therefore, it is of great interest to discover novel DDIs according to their molecular properties and mechanisms in a robust and rigorous way. This paper attempts to predict effective DDIs using the following properties: (1) chemical interaction between drugs; (2) protein interactions between the targets of drugs; and (3) target enrichment of KEGG pathways. The data consisted of 7323 pairs of DDIs collected from the DrugBank and 36,615 pairs of drugs constructed by randomly combining two drugs. Each drug pair was represented by 465 features derived from the aforementioned three categories of properties. The random forest algorithm was adopted to train the prediction model. Some feature selection techniques, including minimum redundancy maximum relevance and incremental feature selection, were used to extract key features as the optimal input for the prediction model. The extracted key features may help to gain insights into the mechanisms of DDIs and provide some guidelines for the relevant clinical medication developments, and the prediction model can give new clues for identification of novel DDIs.

[1]  Kuo-Chen Chou,et al.  Deciphering the effects of gene deletion on yeast longevity using network and machine learning approaches. , 2012, Biochimie.

[2]  Christian von Mering,et al.  STITCH: interaction networks of chemicals and proteins , 2007, Nucleic Acids Res..

[3]  Wenjin Li,et al.  Prediction of protein structural classes using hybrid properties , 2008, Molecular Diversity.

[4]  Anirvan Ghosh,et al.  SMN2 splicing modifiers improve motor function and longevity in mice with spinal muscular atrophy , 2014, Science.

[5]  Lukasz Kurgan,et al.  Accurate prediction of disorder in protein chains with a comprehensive and empirically designed consensus , 2014, Journal of biomolecular structure & dynamics.

[6]  Kuo-Chen Chou,et al.  Prediction of Protein Domain with mRMR Feature Selection and Analysis , 2012, PloS one.

[7]  L. Riboni,et al.  Sphingolipids: Key Regulators of Apoptosis and Pivotal Players in Cancer Drug Resistance , 2014, International journal of molecular sciences.

[8]  Russ B. Altman,et al.  A novel signal detection algorithm for identifying hidden drug-drug interactions in adverse event reports , 2012, J. Am. Medical Informatics Assoc..

[9]  Yu-Dong Cai,et al.  Finding Candidate Drugs for Hepatitis C Based on Chemical-Chemical and Chemical-Protein Interactions , 2014, PloS one.

[10]  Hiroyuki Ogata,et al.  KEGG: Kyoto Encyclopedia of Genes and Genomes , 1999, Nucleic Acids Res..

[11]  M. Troxell,et al.  Membranous nephropathy and nonsteroidal anti-inflammatory agents. , 2013, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[12]  Yuichi Sugiyama,et al.  Quantitative Prediction of In Vivo Drug-Drug Interactions from In Vitro Data Based on Physiological Pharmacokinetics: Use of Maximum Unbound Concentration of Inhibitor at the Inlet to the Liver , 2000, Pharmaceutical Research.

[13]  David J. Greenblatt,et al.  Clinically Important Drug Interactions with Zopiclone, Zolpidem and Zaleplon , 2003, CNS drugs.

[14]  Majid Mohammad Beigi,et al.  Prediction of allergenic proteins by means of the concept of Chou's pseudo amino acid composition and a machine learning approach. , 2012 .

[15]  Hassan Mohabatkar,et al.  Prediction of allergenic proteins by means of the concept of Chou's pseudo amino acid composition and a machine learning approach. , 2012, Medicinal chemistry (Shariqah (United Arab Emirates)).

[16]  Johnathan Canton,et al.  Phagosome maturation in polarized macrophages , 2014, Journal of leukocyte biology.

[17]  R. Sharan,et al.  INDI: a computational framework for inferring drug interactions and their associated recommendations , 2012, Molecular systems biology.

[18]  Kabir-ud-din,et al.  Effect of inorganic salts on the clouding behavior of hydroxypropyl methyl cellulose in presence of amphiphilic drugs. , 2013, Colloids and surfaces. B, Biointerfaces.

[19]  Kuo-Chen Chou,et al.  RSARF: prediction of residue solvent accessibility from protein sequence using random forest method. , 2012, Protein and peptide letters.

[20]  Smriti Khanna,et al.  Cyclopentyl-pyrimidine based analogues as novel and potent IGF-1R inhibitor. , 2015, European journal of medicinal chemistry.

[21]  Jing Lu,et al.  A hybrid method for prediction and repositioning of drug Anatomical Therapeutic Chemical classes. , 2014, Molecular bioSystems.

[22]  Rachelle Buchbinder,et al.  Combination therapy for pain management in inflammatory arthritis (rheumatoid arthritis, ankylosing spondylitis, psoriatic arthritis, other spondyloarthritis). , 2011, The Cochrane database of systematic reviews.

[23]  Kuo-Chen Chou,et al.  Classification and Analysis of Regulatory Pathways Using Graph Property, Biochemical and Physicochemical Property, and Functional Property , 2011, PloS one.

[24]  Yoshihiko Kakinuma,et al.  Nicotinic receptor-dependent and -independent effects of galantamine, an acetylcholinesterase inhibitor, on the non-neuronal acetylcholine system in C2C12 cells. , 2015, International immunopharmacology.

[25]  W. Daniel,et al.  Effect of cytochrome P450 (CYP) inducers on caffeine metabolism in the rat. , 2007, Pharmacological reports : PR.

[26]  Kazue Mizumura,et al.  Absence of mechanical hyperalgesia after exercise (delayed onset muscle soreness) in neonatally capsaicin-treated rats , 2012, Neuroscience Research.

[27]  Leo Breiman,et al.  Random Forests , 2001, Machine Learning.

[28]  Zhijun Qiu,et al.  Improved prediction of protein ligand-binding sites using random forests. , 2011, Protein and peptide letters.

[29]  John M. Barnard,et al.  Chemical Similarity Searching , 1998, J. Chem. Inf. Comput. Sci..

[30]  Ping Zhang,et al.  DDI-CPI, a server that predicts drug–drug interactions through implementing the chemical–protein interactome , 2014, Nucleic Acids Res..

[31]  R. O. Day,et al.  Drug Interactions of Clinical Importance , 1995, Drug safety.

[32]  S. van Buuren,et al.  On the assessment of adverse drug reactions from spontaneous reporting systems: the influence of under‐reporting on odds ratios , 2002, Statistics in medicine.

[33]  Akihiro Hisaka,et al.  General Framework for the Prediction of Oral Drug Interactions Caused by CYP3A4 Induction from In Vivo Information , 2008, Clinical pharmacokinetics.

[34]  T. Atkinson,et al.  What's new in NSAID pharmacotherapy: oral agents to injectables. , 2013, Pain medicine.

[35]  Christian von Mering,et al.  STRING 8—a global view on proteins and their functional interactions in 630 organisms , 2008, Nucleic Acids Res..

[36]  Carrie Kovarik,et al.  Identification and Molecular Analysis of Glycosaminoglycans in Cutaneous Lupus Erythematosus and Dermatomyositis , 2011, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.

[37]  Chen Chu,et al.  A computational method for the identification of new candidate carcinogenic and non-carcinogenic chemicals. , 2015, Molecular bioSystems.

[38]  Ian H. Witten,et al.  Data mining: practical machine learning tools and techniques with Java implementations , 2002, SGMD.

[39]  Matthew J Rossman,et al.  Passive leg movement and nitric oxide-mediated vascular function: the impact of age. , 2015, American journal of physiology. Heart and circulatory physiology.

[40]  Hideaki Nagata,et al.  Short‐term combinational therapy of low‐dose estrogen with selective serotonin re‐uptake inhibitor (fluvoxamine) for oophorectomized women with hot flashes and depressive tendencies , 2005, The journal of obstetrics and gynaecology research.

[41]  G. Amsden,et al.  Macrolide Drug Interactions: An Update , 2000, The Annals of pharmacotherapy.

[42]  N. Das,et al.  Complement and membrane-bound complement regulatory proteins as biomarkers and therapeutic targets for autoimmune inflammatory disorders, RA and SLE. , 2015, Indian journal of experimental biology.

[43]  D. Werling,et al.  Role of sugars in surface microbe-host interactions and immune reaction modulation. , 2007, Veterinary dermatology.

[44]  David S. Wishart,et al.  DrugBank: a comprehensive resource for in silico drug discovery and exploration , 2005, Nucleic Acids Res..

[45]  Yu-Dong Cai,et al.  Prediction of Protein-Protein Interaction Sites by Random Forest Algorithm with mRMR and IFS , 2012, PloS one.

[46]  Wencong Lu,et al.  Predicting the DPP-IV Inhibitory Activity pIC50 Based on Their Physicochemical Properties , 2013, BioMed research international.

[47]  B. Bhaskar,et al.  Design and synthesis of triazolopyrimidine acylsulfonamides as novel anti-mycobacterial leads acting through inhibition of acetohydroxyacid synthase. , 2014, Bioorganic & medicinal chemistry letters.

[48]  B. Matthews Comparison of the predicted and observed secondary structure of T4 phage lysozyme. , 1975, Biochimica et biophysica acta.

[49]  N. Shear,et al.  The Implications and Management of Drug Interactions with Itraconazole, Fluconazole and Terbinafine , 2000, Dermatology.

[50]  P. Bork,et al.  Literature mining for the biologist: from information retrieval to biological discovery , 2006, Nature Reviews Genetics.

[51]  R. Waring,et al.  Sulfotransferase inhibition: potential impact of diet and environmental chemicals on steroid metabolism and drug detoxification. , 2008, Current drug metabolism.

[52]  Noha M Elsharnouby,et al.  Heparin/N-acetylcysteine: an adjuvant in the management of burn inhalation injury: a study of different doses. , 2014, Journal of critical care.

[53]  Tuomas Korhonen,et al.  SFINX—a drug-drug interaction database designed for clinical decision support systems , 2009, European Journal of Clinical Pharmacology.

[54]  S. Mukherjee,et al.  Subversion of membrane transport pathways by vacuolar pathogens , 2011, The Journal of cell biology.

[55]  Philip B. Mitchell,et al.  Drug Interactions of Clinical Significance with Selective Serotonin Reuptake Inhibitors , 1997, Drug safety.

[56]  Moon-Young Yoon,et al.  Synthesis, crystal structure and biological evaluation of substituted quinazolinone benzoates as novel antituberculosis agents targeting acetohydroxyacid synthase. , 2015, European journal of medicinal chemistry.

[57]  T. Pierson,et al.  Direct complement restriction of flavivirus infection requires glycan recognition by mannose-binding lectin. , 2010, Cell host & microbe.

[58]  Ron Kohavi,et al.  A Study of Cross-Validation and Bootstrap for Accuracy Estimation and Model Selection , 1995, IJCAI.

[59]  Y. Martin,et al.  Do structurally similar molecules have similar biological activity? , 2002, Journal of medicinal chemistry.

[60]  Carmen Gil,et al.  cAMP-specific phosphodiesterase inhibitors: promising drugs for inflammatory and neurological diseases , 2014, Expert opinion on therapeutic patents.

[61]  T Lavé,et al.  Qualitative and quantitative assessment of drug-drug interaction potential in man, based on Ki, IC50 and inhibitor concentration. , 2004, Current drug metabolism.

[62]  N. Rotstein,et al.  Synthesis of sphingosine is essential for oxidative stress-induced apoptosis of photoreceptors. , 2010, Investigative ophthalmology & visual science.

[63]  อนิรุธ สืบสิงห์,et al.  Data Mining Practical Machine Learning Tools and Techniques , 2014 .

[64]  Yu-Chu Tian,et al.  An Ensemble Method for Predicting Subnuclear Localizations from Primary Protein Structures , 2013, PloS one.

[65]  C. Ding,et al.  Gene selection algorithm by combining reliefF and mRMR , 2007, 2007 IEEE 7th International Symposium on BioInformatics and BioEngineering.

[66]  Kiyomi Ito,et al.  Database analyses for the prediction of in vivo drug-drug interactions from in vitro data. , 2004, British journal of clinical pharmacology.

[67]  Alex Phipps,et al.  Comparison of Different Algorithms for Predicting Clinical Drug-Drug Interactions, Based on the Use of CYP3A4 in Vitro Data: Predictions of Compounds as Precipitants of Interaction , 2009, Drug Metabolism and Disposition.

[68]  S. Nelson,et al.  Drug-Drug Interactions: Toxicological Perspectives , 2001, Drug-Drug Interactions.

[69]  Giorgio Valentini,et al.  Network-Based Drug Ranking and Repositioning with Respect to DrugBank Therapeutic Categories , 2013, IEEE/ACM Transactions on Computational Biology and Bioinformatics.

[70]  Mostafa M Ghorab,et al.  Design and synthesis of novel thiophenes bearing biologically active aniline, aminopyridine, benzylamine, nicotinamide, pyrimidine and triazolopyrimidine moieties searching for cytotoxic agents. , 2014, Acta poloniae pharmaceutica.

[71]  P. Neuvonen,et al.  Drug interactions with lipid‐lowering drugs: Mechanisms and clinical relevance , 2006, Clinical pharmacology and therapeutics.

[72]  P. Nelson,et al.  Cell surface engineering of renal cell carcinoma with glycosylphosphatidylinositol-anchored TIMP-1 blocks TGF-β1 activation and reduces regulatory ID gene expression , 2012, Biological chemistry.

[73]  Naoyuki Taniguchi,et al.  Binding of langerin/CD207 to keratan sulfate disaccharide, Gal (6SO3) β1, 4-GlcNAc (6SO3) and its triangle derivative in vitro and in vivo: possible drug targets for COPD (chronic obstructive pulmonary disease) , 2014 .

[74]  Peer Bork,et al.  Extraction of regulatory gene/protein networks from Medline , 2006, Bioinform..

[75]  Yamaguchi Yoshiki,et al.  ランゲリン/CD207のケラタン硫酸二糖,Gal(6SO 3 )β1,4-GlcNAc(6SO 3 )とそのトライアングル誘導体へのin vitroおよびin vivoでの結合:COPD(慢性閉塞性肺疾患)の創薬標的候補 | 文献情報 | J-GLOBAL 科学技術総合リンクセンター , 2014 .

[76]  Y. Akao,et al.  Rasagiline and selegiline, inhibitors of type B monoamine oxidase, induce type A monoamine oxidase in human SH-SY5Y cells , 2013, Journal of Neural Transmission.

[77]  Sukanta Mondal,et al.  MOWGLI: prediction of protein–MannOse interacting residues With ensemble classifiers usinG evoLutionary Information , 2016, Journal of biomolecular structure & dynamics.

[78]  Lucy Rowell,et al.  Assessment of disease-drug-drug interaction between single-dose tocilizumab and oral contraceptives in women with active rheumatoid arthritis. , 2014, International journal of clinical pharmacology and therapeutics.

[79]  H. Homma,et al.  Biochemistry and molecular biology of drug-metabolizing sulfotransferase. , 1994, The International journal of biochemistry.

[80]  C. Steinbeck,et al.  Recent developments of the chemistry development kit (CDK) - an open-source java library for chemo- and bioinformatics. , 2006, Current pharmaceutical design.

[81]  W. Ambrosius,et al.  Application of Random Forests Methods to Diabetic Retinopathy Classification Analyses , 2014, PloS one.

[82]  Mario Zappia,et al.  Selegiline: A Reappraisal of Its Role in Parkinson Disease , 2012, Clinical neuropharmacology.

[83]  R Scott Obach,et al.  Drug metabolism and drug interactions: application and clinical value of in vitro models. , 2003, Current drug metabolism.

[84]  G. Shi,et al.  Drug release behavior of poly (lactic-glycolic acid) grafting from sodium alginate (ALG-g-PLGA) prepared by direct polycondensation , 2015, Journal of biomaterials science. Polymer edition.

[85]  Honglin Li,et al.  An improved sequence based prediction protocol for DNA-binding proteins using SVM and comprehensive feature analysis , 2012, BMC Bioinformatics.

[86]  L. Horrocks,et al.  Interactions between neural membrane glycerophospholipid and sphingolipid mediators: A recipe for neural cell survival or suicide , 2007, Journal of neuroscience research.

[87]  Andreas J Kungl,et al.  PA401, a novel CXCL8-based biologic therapeutic with increased glycosaminoglycan binding, reduces bronchoalveolar lavage neutrophils and systemic inflammatory markers in a murine model of LPS-induced lung inflammation. , 2015, Cytokine.

[88]  Hongkang Mei,et al.  Systematic Prediction of Pharmacodynamic Drug-Drug Interactions through Protein-Protein-Interaction Network , 2013, PLoS Comput. Biol..

[89]  Chen Chu,et al.  Predicting the types of metabolic pathway of compounds using molecular fragments and sequential minimal optimization. , 2016, Combinatorial chemistry & high throughput screening.

[90]  Pierre Baldi,et al.  Assessing the accuracy of prediction algorithms for classification: an overview , 2000, Bioinform..

[91]  Kuo-Chen Chou,et al.  Predicting the network of substrate-enzyme-product triads by combining compound similarity and functional domain composition , 2010, BMC Bioinformatics.

[92]  Aleksandra Galetin,et al.  PREDICTION OF TIME-DEPENDENT CYP3A4 DRUG-DRUG INTERACTIONS: IMPACT OF ENZYME DEGRADATION, PARALLEL ELIMINATION PATHWAYS, AND INTESTINAL INHIBITION , 2006, Drug Metabolism and Disposition.

[93]  J. García-Sevilla,et al.  Increased α2- and β1-adrenoceptor densities in postmortem brain of subjects with depression: differential effect of antidepressant treatment. , 2014, Journal of affective disorders.

[94]  Perumal Subramaniam,et al.  Synthesis, structural elucidation, biological, antioxidant and nuclease activities of some 5-Fluorouracil-amino acid mixed ligand complexes. , 2015, Spectrochimica acta. Part A, Molecular and biomolecular spectroscopy.

[95]  K. Chou,et al.  Predicting Anatomical Therapeutic Chemical (ATC) Classification of Drugs by Integrating Chemical-Chemical Interactions and Similarities , 2012, PloS one.

[96]  A. Esmaeili,et al.  Prediction of GABAA receptor proteins using the concept of Chou's pseudo-amino acid composition and support vector machine. , 2011, Journal of theoretical biology.

[97]  Aleksandra Galetin,et al.  Prediction of In Vivo Drug-Drug Interactions from In Vitro Data , 2006, Clinical pharmacokinetics.

[98]  Fuhui Long,et al.  Feature selection based on mutual information criteria of max-dependency, max-relevance, and min-redundancy , 2003, IEEE Transactions on Pattern Analysis and Machine Intelligence.

[99]  Tao Huang,et al.  A method to distinguish between lysine acetylation and lysine ubiquitination with feature selection and analysis , 2015, Journal of biomolecular structure & dynamics.

[100]  Paul Kubes,et al.  Interference with Glycosaminoglycan-Chemokine Interactions with a Probe to Alter Leukocyte Recruitment and Inflammation In Vivo , 2014, PloS one.